
The FDA has approved its first treatment for peanut allergy in patients between ages four and 17. The drug is …
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

